FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. | PSNet

Provide Feedback |

Register

Press Release/Announcement

FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products.

August 7, 2024

July 26, 2024;

Patient-administered medications can lead to a variety of errors that have the potential to harm. This announcement raises awareness of the potential for dosing errors due to measurement mistakes of injectable medications and reviews reported adverse events and hospitalizations associated with the errors.

Related Resources From the Same Author(s)

Five Medication Safety Tips for Older Adults.

February 15, 2024

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Safety Problems With Your Child's Medical Device?

July 31, 2013

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

September 29, 2010

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

My Medicines.

July 9, 2014

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

View More

Related Resources

2024 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report.

March 20, 2024

Reducing potential errors associated with insulin administration: an integrative review.

December 14, 2022

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

ISMP medication error report analysis.

June 16, 2019

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

US poison control center calls for infants 6 months of age and younger.

February 15, 2017

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

August 11, 2010

View More

See More About The Topic

Ordering/Prescribing Errors

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364